The European agency has started a review of sodium oxybate to assess its use to treat alcohol withdrawal syndrome and support ...

The European Union's medicine regulator has begun a review of some medicines that contain sodium oxybate and are used to treat alcohol withdrawal syndrome, it said on Friday. Sodium oxybate is an ...

Revenue for Madrigal’s Rezdiffra, already approved in the US, is expected to skyrocket over the coming decade.

The European Medicines Agency’s human medicines committee (CHMP) adopted positive opinions for six biosimilar medicines at its June meeting.

The dapivirine ring was originally approved in July 2020 to reduce the risk for HIV-1 infection in women 18 years and older ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended five novel medicines for approval at its ...

Johnson & Johnson (NYSE:JNJ) said that an advisory committee of the EU drug regulator, the European Medicines Agency (EMA), ...

Madrigal Pharmaceuticals said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of its Rezdiffra treatment for adults with the liver disease ...

One difficulty in assessing phthalate safety is that there isn’t just one type. Phthalates are a large family of chemicals, ...

If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated neuroendocrine tumors, regardless of tumor site, grade or previous non-somato ...

ORION CORPORATION PRESS RELEASE 20 JUNE 2025 at 13.30 EEST CHMP recommends third indication for darolutamide for patients ...